Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner

被引：1
|
作者：
Campani, Claudia [1 ]
Rimassa, Lorenza [2 ,3 ]
Personeni, Nicola [2 ,3 ]
Marra, Fabio [1 ]
机构：
[1] Univ Florence, Dept Expt & Clin Med, Internal Med & Hepatol Unit, Florence, Italy
[2] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy
[3] Humanitas Univ, Dept Biomed Sci, Milan, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 22期
关键词：
RECEPTOR-LIKE KINASE-1; PHASE-III; DOUBLE-BLIND; LIGAND TRAP; SORAFENIB; DALANTERCEPT; THERAPY; CABOZANTINIB; COMBINATION; RECURRENT;
D O I：
10.21037/atm-20-3788
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
    Guardascione, Michela
    Toffoli, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19
  • [42] NLR stability predicts response to immune checkpoint inhibitors in advanced hepatocellular carcinoma
    Du, Jiajia
    Huang, Zhiyong
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] The role of c-MET inhibitors in advanced hepatocellular carcinoma: now and future
    Woo, Hyun Young
    Heo, Jeong
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [44] Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates
    Shek, Dmitrii
    Read, Scott A.
    Nagrial, Adnan
    Carlino, Matteo S.
    Gao, Bo
    George, Jacob
    Ahlenstiel, Golo
    [J]. ONCOLOGIST, 2021, 26 (07): : E1216 - E1225
  • [45] Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain
    Castellano, Daniel
    Duh, Mei Sheng
    Korves, Caroline
    Suthoff, Ellison Dial
    Neary, Maureen
    Hernandez Pastor, Luis Javier
    Bellmunt, Joaquim
    [J]. EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 455 - 463
  • [46] Hepatocellular Carcinoma Cancer Immunotherapy plus Angiogenesis Inhibitors - soon the new Therapy Standard for HCC?
    Vetter, Christine
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (11) : 642 - 642
  • [47] Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions
    Hilmi, Marc
    Neuzillet, Cindy
    Calderaro, Julien
    Lafdil, Fouad
    Pawlotsky, Jean-Michel
    Rousseau, Benoit
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [48] Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
    Lee, J.
    Ng, K.
    Wong, L.
    Ang, A.
    Tan, S. H.
    Tai, D.
    Choo, S. P.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 23 - 23
  • [49] Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
    Ng, Kennedy Yao Yi
    Wong, Lawrence Wen Jun
    Ang, Andrea Jing Shi
    Lee, Ailica Wan Xin
    Tay, Desiree Shu Hui
    Tan, Jack Jie En
    Tan, Sze Huey
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (03) : 312 - 319
  • [50] Challenges of advanced hepatocellular carcinoma
    Colagrande, Stefano
    Inghilesi, Andrea L.
    Aburas, Sami
    Taliani, Gian G.
    Nardi, Cosimo
    Marra, Fabio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (34) : 7645 - 7659
12345